Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $27.5000 (-5.17%) ($27.5000 - $30.0000) on Wed. Mar. 1, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.99% (three month average) | RSI | 65 | Latest Price | $27.5000(-5.17%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -2.4% a day on average for past five trading days. | Weekly Trend | CAPR advances 3.9% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) EWI(7%) PEJ(7%) SKYY(7%) XLF(7%) ARKK(6%) | Factors Impacting CAPR price | CAPR will decline at least -2.495% in a week (0% probabilities). GDX(-7%) TLT(-6%) SIL(-6%) GLD(-6%) VIXM(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.495% (StdDev 4.99%) | Hourly BBV | 0 () | Intraday Trend | -8% | | | |
|
Resistance Level | $28.31 | 5 Day Moving Average | $29.82(-7.78%) | 10 Day Moving Average | $30.49(-9.81%) | 20 Day Moving Average | $28.31(-2.86%) | To recent high | -15.4% | To recent low | 26.1% | Market Cap | $542m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |